Repligen Corp header image

Repligen Corp

RGEN

Equity

ISIN null / Valor 965900

NASDAQ (2026-03-23)

USD 116.35+2.17%

Repligen Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Repligen Corp is a company that provides technology solutions for the development and manufacture of various biopharmaceutical products, including plasmid DNA, viral vectors, mRNA, and new modalities like whole cells and cultivated meat. With over 15 years of experience and a track record of successful implementation in commercial processes, Repligen's XCell® ATF Technology stands out as a scalable and efficient method for upstream intensification. Additionally, the company offers the CTech™ FlowVPX® spectrophotometer system, designed to meet regulatory GMP requirements by providing reliable real-time concentration measurements throughout the downstream process.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-16.9%1Y

-28.5%3Y

-43.7%5Y

Performance

49.8%1Y

47.6%3Y

50.2%5Y

Volatility

6554 M

Market cap (USD)

819,862

Daily traded volume (Shares)

144.91 / 141.5

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

QXO Inc

QXO Inc Valor: 135786409

Annual Return

-50%0%+50%

Risk level

110

8.91%USD 20.30

Planisware

Planisware Valor: 134585679

Annual Return

-50%0%+50%

Risk level

110

-0.41%EUR 14.56

AdCapital AG

AdCapital AG Valor: 324972

Annual Return

-50%0%+50%

Risk level

110

-0.62%EUR 0.80

Blueprint Medicines Corp

Blueprint Medicines Corp Valor: 27670715

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 129.46

UiPath Inc

UiPath Inc Valor: 110831715

Annual Return

-50%0%+50%

Risk level

110

0.58%USD 12.13

Zegona Communications PLC

Zegona Communications PLC Valor: 27392586

Annual Return

-50%0%+50%

Risk level

110

0.90%GBP 16.80

Klaviyo Inc

Klaviyo Inc Valor: 129329789

Annual Return

-50%0%+50%

Risk level

110

2.10%USD 18.97

Kura Oncology Inc

Kura Oncology Inc Valor: 28160920

Annual Return

-50%0%+50%

Risk level

110

0.73%USD 8.32

Arendals Fossekompani ASA

Arendals Fossekompani ASA Valor: 599143

Annual Return

-50%0%+50%

Risk level

110

-0.95%NOK 156.50

SiriusXM Holdings Inc

SiriusXM Holdings Inc Valor: 138155198

Annual Return

-50%0%+50%

Risk level

110

2.18%USD 22.47

SIX

FactSet

Clearbit

Logos provided by Clearbit